Vaccine, COVID-19, Coronavirus, KOLUMN Magazine, KOLUMN, KINDR'D Magazine, KINRD'D, Willoughby Avenue, Wriit,

Johnson & Johnson pauses clinical trials for a Covid-19 vaccine over participant’s illness | NBC News

Read Time 2 min.

Johnson & Johnson pauses clinical trials for a Covid-19 vaccine over participant’s illness | NBC News

The trial was paused in compliance with regulatory standards after an “unexplained” illness in one of its participants, the company said.

Doha Madani, NBC News

Johnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, just weeks after it announced that trials were in their final stage.

A pause is not entirely unexpected in vaccine trials. When another vaccine trial was temporarily stopped last month, experts hailed the move as an example of the scientific rigor that is being maintained despite the understandably intense public interest in a Covid-19 vaccine.

The Johnson & Johnson trial was paused in compliance with regulatory standards after one of its participants developed an “unexplained” illness, the company said in a news release Monday night. It said the participant’s condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board.

 

—  Credits


Featured Image, Cheryl Gerber/Courtesy of Johnson & Johnson via AP
Full article @ NBC News

 

—  Related

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. J&J is one of the world’s most valuable companies.

Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015. Johnson & Johnson’s brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson’s Baby products, Neutrogena skin and beauty productsClean & Clear facial wash and Acuvue contact lenses.

Source – Johnson & Johnson (Updated: 13 October 2020) Wikipedia. Available at https://en.wikipedia.org/wiki/Johnson_%26_Johnson, (Accessed: 13 October 2020)